QUEBEC CITY, Oct. 26 /PRNewswire-FirstCall/ - Atrium Biotechnologies Inc. today announced that its quarterly conference call and webcast have been scheduled for Wednesday November 8, 2006 at 5 p.m. Eastern time. The call will follow the press release of Atrium's 2006 third quarter results issued on November 8, 2006 following the close of the markets. Participants may access the call by using the following numbers: 416-644-3430, 514-807-8791 or 866-249-1964 or via the Company's website at www.atrium-bio.com in the "Investors" section.
A replay of the webcast will also be available on our website www.atrium-bio.com in the "Investors" section for a period of 30 days.
About Atrium Biotechnologies
Atrium Biotechnologies Inc. is a leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. Atrium focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 40 countries, primarily in North America, Europe and Asia.
Additional information about Atrium is available on its Web site at www.atrium-bio.com.
ATRIUM BIOTECHNOLOGIES INC.CONTACT: Investor Relations: John Dempsey, Vice President, Finance andChief Financial Officer, (418) 652-1116, ext. 287, jdempsey@atrium-bio.com;Media Relations: Frederic Tremblay, HKDP, (514) 395-0375, ext. 234,ftremblay@hkdp.qc.ca
